Clinical Trial Update: Evaluate Safety, Efficacy and Pharmacokinetics [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial in metastatic breast cancer completed with results on safety, efficacy, and pharmacokinetics; results posted in 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Celltrion | Conditions: Metastatic Breast Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2025-01-24